Thermo Fisher Scientific Inc (BSP:TMOS34)
R$ 54.95 +3.5 (+7.04%) Market Cap: 979.30 Bil Enterprise Value: 1.19 Tn PE Ratio: 27.80 PB Ratio: 3.62 GF Score: 74/100

Q1 2026 Thermo Fisher Scientific Inc Earnings Call Transcript

Apr 23, 2026 / 12:30PM GMT
Release Date Price: R$47.85 (-10.71%)

Key Points

Positve
  • Thermo Fisher Scientific Inc (TMO) reported a 6% increase in revenue for Q1 2026, reaching $11.01 billion.
  • The company completed the acquisition of Clario, which added $30 million in revenue and $0.01 to adjusted EPS for the quarter.
  • Thermo Fisher Scientific Inc (TMO) raised its full-year revenue guidance to a range of $47.3 billion to $48.1 billion, reflecting 6% to 8% growth over 2025.
  • The company launched several new technologies, including the Thermo Scientific Glacios 3 Cryo-TEM and the Thermo Scientific TSQ Certis mass spectrometer, enhancing its industry leadership.
  • Thermo Fisher Scientific Inc (TMO) repurchased $3 billion of shares and increased its dividend by 10% during the quarter, demonstrating strong capital return to shareholders.
Negative
  • Revenue in the academic and government sector declined due to muted macro conditions in the US and China.
  • The diagnostics and healthcare segment saw a mid-single-digit revenue decline, partly due to a weaker respiratory season.
  • The Analytical Instruments segment experienced a 2% decrease in organic revenue, impacted by lower demand from academic and government customers.
  • The company anticipates modest inflationary pressures due to the conflict in the Middle East, which could impact future financial performance.
  • Thermo Fisher Scientific Inc (TMO) faces challenges from tariffs and related foreign exchange impacts, which affected operating margins.
Operator

Good morning, ladies and gentlemen, and welcome to the Thermo Fisher Scientific 2026 first-quarter conference call. (Operator Instructions)

I would now like to introduce our moderator for the call, Mr. Rafael Tejada, Vice President of Investor Relations. Mr. Tejada, you may begin.

Rafael Tejada
Thermo Fisher Scientific Inc - Vice President - Investor Relations

Good morning, and thank you for joining us. On the call with me today is Marc Casper, our Chairman and Chief Executive Officer; and Jim Meyer, Senior Vice President and Chief Financial Officer. Please note this call is being webcast live and will be archived on the Investors section of our website, thermofisher.com under the heading News, Events & Presentations until July 22, 2026.

A copy of the press release of our first-quarter earnings is available in the Investors section of our website under the heading, financials. So before we begin, let me briefly cover our safe harbor statement. Various remarks that we may make about the company's future expectations, plans and prospects

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot